Bertrand Routy

Research Update: Clinician-Scientist Award supports breakthrough insights into how the microbiome shapes immunotherapy response in lung cancer

In 2022, Dr. Bertrand Routy was amongst the first four researchers to receive the MOHCCN Clinician-Scientist Awards to study how the microbiome mediates immunotherapy response in patients with non-sma...

MOHCCN Clinician Scientist finds that fecal transplants show promise in improving melanoma treatment

In a first-of-its-kind Canadian clinical trial published in the journal Nature Medicine, a group of researchers that included MOHCCN Clinician-Scientist awardee Dr. Bertrand Routy has found that fecal...